PATENT CLAIM ANALYSIS

Application Number: 15933660
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "274100"]

Abstract:
The invention provides a peptide obtainable from  C. albicans  as well as variants and fragments thereof, and labelled forms of these. The peptide is immunogenic and specific binding partners for the peptide and labelled forms of these specific binding partners form a further aspect of the invention. The peptide is a fragment of the ECE1 protein and has been found to be both immunogenic and act as a pore-forming toxin. A range of therapeutic and diagnostic applications for the peptide and the specific binding partners for it form further aspects of the invention. In addition, the peptide may be used in screens for identifying compounds having useful anti-fungal activity.

Claim (Index 7):
The method of  claim 6  wherein the infection is an oral or mucosal infection by  Candida albicans.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 90.0
- Lexical Diversity: 1.87097
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14783237', '12988595', '15484463', '10418303', '10117121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7467103879861499
- 35 USC 102 Novelty (BERT): 0.5808192980067209
- Combined Prediction Score: 0.730121278988207
- Mean Citation Score: 306.83077999999995
- Max Citation Score: 576.8105
- Similarity Product: 360.3563537243307

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test